Denali Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History

Denali Advisors LLC

  • $916 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$17.85 - $26.95 $24,990 - $37,730
-1,400 Reduced 53.85%
1,200 $23,000
Q2 2022

Jul 18, 2022
SELL
$16.33 - $22.2 $17,962 - $24,420
-1,100 Reduced 29.73%
2,600 $55,000
Q4 2021

Jan 21, 2022
BUY
$14.98 - $25.5 $55,426 - $94,350
3,700 New
3,700 $77,000

Others Institutions Holding ARQT

# of Institutions
196
Shares Held
130M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $797M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email